Anti-LDHB Polyclonal Antibody (CABT-L2011) Knockout Validated

Rabbit Anti-Human LDHB (Met1~Leu334) Polyclonal Antibody for WB

Specifications


Host Species
Rabbit
Antibody Isotype
IgG
Species Reactivity
Human, Mouse, Rat
Immunogen
Recombinant fragment corresponding to human LDHB (Met1~Leu334)
Conjugate
Unconjugated

Applications


Application Notes
Recommended dilution: WB: 0.5-2 ug/ml
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.

Data Examples


Knockout Varification: Lane 1: Wild-type Jurkat cell lysate. Lane 2: LDHB knockout Jurkat cell lysate. Predicted MW: 37kDa, Observed MW: 35kDa
Figure. Western Blot. Sample. Lane1: Human Jurkat Cells; Lane2: Human A431 Cells; Lane3: Mouse Testis Tissue; Lane4: Mouse Kidney Tissue; Lane5: Human Liver Tissue.

Target


Alternative Names
LDH-B; LDH-H; Renal carcinoma antigen NY-REN-46
Entrez Gene ID
UniProt ID

Product Background


Pathway
Abnormal metabolism in phenylketonuria; Cysteine and methionine metabolism; Disease; Glycolysis / Gluconeogenesis; Glycolysis and Gluconeogenesis; Metabolic pathways; Metabolism; Propanoate metabolism;

Citations


Have you cited CABT-L2011 in a publication? Let us know and earn a reward for your research.

Custom Antibody Labeling


We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More

Customer Reviews


Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket

References


Li, M; Aliotta, JM; et al. Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells. PROTEOMICS 12:2203-2211(2012).
Lehmann, BD; Pietenpol, JA; et al. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes. JOURNAL OF PATHOLOGY 232:142-150(2014).

Online Inquiry

Name:
Phone: *
E-mail Address: *
Service & Products Interested: *
Project Description:
Verification Code: * Please input "diagnostics" as verification code.

Online Inquiry

  Interested in larger quantities ? request a quote!
  Protocol may be improved. Please feel free to contact us to obtain the latest version.!

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

OUR PROMISE TO YOU Guaranteed product quality expert customer support

Inquiry Basket